Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Amendment of Schedule 131.

(1)

Schedule 1 (further provisions for classification of medicinal products) is amended as follows.

(2)

In Part 1 M1 (descriptions of certain medicinal products to be available only on prescription), in paragraph 1—

(a)

omit “and” at the end of sub-paragraph (f);

(b)

insert “
; and
” at the end of sub-paragraph (g); and

(c)

after sub-paragraph (g) insert—

“(h)

a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, the product is classified as a prescription only medicine.”.

(3)

In Part 2 M2 (descriptions of certain medicinal products to be available only from a pharmacy), in paragraph 3—

(a)

insert “
; and
” at the end of sub-paragraph (c); and

(b)

after sub-paragraph (c) insert—

“(d)

a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, it is only to be available from a pharmacy.”.